Search results
This series contains publications from the National Diabetes Core Audit and historic publications from the Diabetes Prevention Programme, Insulin Pump reports and Transition reports.
Latest publication: National Diabetes Audit (NDA) 2025-26 quarterly report for England, Integrated Care Board (ICB), Primary Care Network (PCN) and GP practice
National Pulmonary Hypertension Audit
Latest publication: National Pulmonary Hypertension Audit,16th Annual Report
Pulmonary hypertension (PH) is a rare disease which occurs at any age, has many causes, and often shortens life expectancy. In the UK, seven hospitals are designated to diagnose and treat PH in adults, and one hospital for children. The National Audit of Pulmonary Hypertension is an audit of processes...
NaDIA-Harms is a mandatory year-round collection of four harms that can occur to diabetic inpatients in Acute hospitals in England.
This is the quarterly release of data from the National Diabetes Audit (NDA). It is the mid-year data release for the second extraction of NDA 2019-20 data. It shows progress to date covering the period 1 January to 30 September 2019. The first data extraction was withdrawn this year so that the delayed...
The National Diabetes Audit (NDA) is part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP) which is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and funded by NHS England and the Welsh Government. The NDA is managed by NHS Digital in partnership with Diabetes...
Pulmonary hypertension (PH) is a rare disease which occurs at any age, has many causes, and often shortens life expectancy. In the UK, seven hospitals are designated to diagnose and treat PH in adults, and one hospital for children. The National Audit of Pulmonary Hypertension is an audit of processes...
This is a jointly funded partnership project with the British Gynaecological Cancer Society, the British Association of Gynaecological Pathologists, and The Eve Appeal and Peaches Womb Cancer Trust.